International time trends in sudden unexpected infant death, 1969-2012.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
11 08 2020
Historique:
received: 26 02 2020
accepted: 03 08 2020
entrez: 13 8 2020
pubmed: 13 8 2020
medline: 15 5 2021
Statut: epublish

Résumé

Sudden unexpected infant death (SUID) - including sudden infant death syndrome (SIDS) - continues to be a major contributor to infant mortality worldwide. Our objective was to analyse time trends and to identify country-clusters. The National Statistical Offices of 52 countries provided the number of deaths and live births (1969-2012). We calculated infant mortality rates per 1000 live births for SUID, SIDS, and all-cause mortality. Overall, 29 countries provided sufficient data for time course analyses of SUID. To sensitively model change over time, we smoothed the curves of mortality rates (1980-2010). We performed a hierarchical cluster analysis to identify clusters of time trends for SUID and SIDS, including all-cause infant mortality. All-cause infant mortality declined from 28.5 to 4.8 per 1000 live births (mean 12.4; 95% confidence interval 12.0-12.9) between 1969 and 2012. The cluster analysis revealed four country-clusters. Clusters 1 and 2 mostly contained countries showing the typical peak of SUID mortality during the 1980s. Cluster 1 had higher SUID mortality compared to cluster 2. All-cause infant mortality was low in both clusters but higher in cluster 1 compared to cluster 2. Clusters 3 and 4 had low rates of SUID without a peak during the 1980s. Cluster 3 had the highest all-cause infant mortality of all clusters. Cluster 4 had an intermediate all-cause infant mortality. The time trends of SUID and SIDS mortality were similar. The country-specific time trends in SUID varied considerably. The identification of country-clusters may promote research into how changes in sleep position, smoking, immunisation, or other factors are related to our findings.

Sections du résumé

BACKGROUND
Sudden unexpected infant death (SUID) - including sudden infant death syndrome (SIDS) - continues to be a major contributor to infant mortality worldwide. Our objective was to analyse time trends and to identify country-clusters.
METHODS
The National Statistical Offices of 52 countries provided the number of deaths and live births (1969-2012). We calculated infant mortality rates per 1000 live births for SUID, SIDS, and all-cause mortality. Overall, 29 countries provided sufficient data for time course analyses of SUID. To sensitively model change over time, we smoothed the curves of mortality rates (1980-2010). We performed a hierarchical cluster analysis to identify clusters of time trends for SUID and SIDS, including all-cause infant mortality.
RESULTS
All-cause infant mortality declined from 28.5 to 4.8 per 1000 live births (mean 12.4; 95% confidence interval 12.0-12.9) between 1969 and 2012. The cluster analysis revealed four country-clusters. Clusters 1 and 2 mostly contained countries showing the typical peak of SUID mortality during the 1980s. Cluster 1 had higher SUID mortality compared to cluster 2. All-cause infant mortality was low in both clusters but higher in cluster 1 compared to cluster 2. Clusters 3 and 4 had low rates of SUID without a peak during the 1980s. Cluster 3 had the highest all-cause infant mortality of all clusters. Cluster 4 had an intermediate all-cause infant mortality. The time trends of SUID and SIDS mortality were similar.
CONCLUSIONS
The country-specific time trends in SUID varied considerably. The identification of country-clusters may promote research into how changes in sleep position, smoking, immunisation, or other factors are related to our findings.

Identifiants

pubmed: 32781989
doi: 10.1186/s12887-020-02271-x
pii: 10.1186/s12887-020-02271-x
pmc: PMC7418369
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

377

Références

BMJ. 1996 Jul 27;313(7051):191-5
pubmed: 8696193
Int J Epidemiol. 2005 Aug;34(4):874-87
pubmed: 15843394
Pediatrics. 2008 Sep;122(3):660-6
pubmed: 18762537
Early Hum Dev. 2003 Dec;75 Suppl:S175-9
pubmed: 14693403
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Natl Vital Stat Rep. 2001 May 18;49(2):1-32
pubmed: 11381674
Am J Epidemiol. 2006 Apr 15;163(8):762-9
pubmed: 16582034
Health Aff (Millwood). 2002 Mar-Apr;21(2):164-78
pubmed: 11900156
Vaccine. 2007 Jun 21;25(26):4875-9
pubmed: 17400342
Early Hum Dev. 2001 Aug;64(1):7-20
pubmed: 11408104
N Engl J Med. 2009 Aug 20;361(8):795-805
pubmed: 19692691
Lancet. 2006 Jan 28;367(9507):314-9
pubmed: 16443038
Am J Public Health. 2000 Apr;90(4):527-31
pubmed: 10754964
JAMA. 1998 Jul 22-29;280(4):329-35
pubmed: 9686549
Forensic Sci Med Pathol. 2019 Dec;15(4):622-628
pubmed: 31502215
Lancet. 1998 Jan 31;351(9099):356-61
pubmed: 9652634
Arch Pediatr Adolesc Med. 2009 Dec;163(12):1122-8
pubmed: 19996049
Pediatrics. 2004 Jul;114(1):234-8
pubmed: 15231934
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
Pediatrics. 2005 May;115(5):1247-53
pubmed: 15867031
BMC Pediatr. 2015 Jan 28;15:1
pubmed: 25626628
Arch Dis Child. 2015 Nov;100(11):1018-23
pubmed: 26163119
J Forensic Leg Med. 2012 Nov;19(8):455-6
pubmed: 23084308
Lancet. 2004 Jan 17;363(9404):185-91
pubmed: 14738790
Pediatrics. 2016 Nov;138(5):
pubmed: 27940805
Med Clin (Barc). 1996 May 4;106(17):649-52
pubmed: 8691909
Arch Dis Child. 1997 Jul;77(1):23-7
pubmed: 9279146

Auteurs

Jacqueline Müller-Nordhorn (J)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Germany.
Bavarian Cancer Registry, Bavarian Health and Food Safety Authority, Nuremberg, Germany.

Alice Schneider (A)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.

Ulrike Grittner (U)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.

Konrad Neumann (K)

Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.

Thomas Keil (T)

Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
Institute for Health Resort Medicine and Health Promotion, Bavarian Health and Food Safety Authority, Bad Kissingen, Germany.

Stefan N Willich (SN)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Germany.

Sylvia Binting (S)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Germany. sylvia.binting@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH